Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MOSUNETUZUMAB vs MUROMONAB-CD3: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MOSUNETUZUMAB vs MUROMONAB-CD3: Safety Overview

Metric MOSUNETUZUMAB MUROMONAB-CD3
Total FAERS Reports 506 114
Deaths Reported 96 28
Death Rate 19.0% 24.6%
Hospitalizations 328 28
Average Patient Age 65.0 yrs 30.2 yrs
% Female Patients 43.7% 45.0%
Manufacturer Genentech, Inc. N/A
Route SUBCUTANEOUS N/A